An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera

Journal of Environmental Science and Health - Part C Environmental Carcinogenesis and Ecotoxicology Reviews

Volumn 24, Issue 1, 2006, Pages 103-154

  Boudreau, Mary D ^a   Beland, Frederick A ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Acemannan; Aloe vera; Aloe vera gel; Aloe vera latex; Anthraquinone; Polymannans; Toxicological effects

Indexed keywords

BIOLOGICAL ORGANS; DISEASES; ELECTROLYTES; GELS; TOXICITY;

ACEMANNAN; ALOE VERA; ALOE VERA GEL; ALOE VERA LATEX; ANTHRAQUINONE; POLYMANNANS; TOXICOLOGICAL EFFECTS;

PLANTS (BOTANY);

ACEMANNAN; ACICLOVIR; ALOE BARBADENSIS EXTRACT; ALOE EMODIN; ALOE EMODIN ANTHRONE; ALOE VERA LATEX; ALOIN; ALPHA TOCOPHEROL; AMPICILLIN; ANTHRAQUINONE; ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; BACITRACIN; BENZOYL PEROXIDE; BUTYLCRESOL; CAPSAICIN; GLYCOSIDE; IMMUNOMODULATING AGENT; INDOMETACIN; NALIDIXIC ACID; PETROLATUM; POLYMER; POLYSACCHARIDE; PSEUDOMONIC ACID; RETINOIC ACID; RHEIN; SCARLET RED; SULFADIAZINE SILVER; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACHOLIC BOWEL MOVEMENT; ACUTE HEPATITIS; ALTERNATIVE MEDICINE; ANAPHYLACTOID PURPURA; ARTHRALGIA; BILIRUBINOSTASIS; BURN; CANCER; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONSTIPATION; CONTACT DERMATITIS; DEFECATION DISORDER; DERMATITIS; DIABETES MELLITUS; DIARRHEA; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; ELECTROLYTE DISTURBANCE; ERYTHEMA; EVALUATION; FETUS DISEASE; GASTROINTESTINAL SYMPTOM; GENOTOXICITY; GRIPPING; HEART ARRHYTHMIA; HERB DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; HYPOKALEMIA; INTESTINE MOTILITY; ISCHEMIC HEART DISEASE; JAUNDICE; KIDNEY DYSFUNCTION; KIDNEY INJURY; LAZY BOWEL SYNDROME; LEG ULCER; LIVER NECROSIS; LYMPHOCYTIC INFILTRATION; MATERNAL DISEASE; MECONIUM; NEPHRITIS; NONHUMAN; PELVIC DISEASE; PELVIS CONGESTION; PHOTODERMATOSIS; PHOTOTOXICITY; PLANT LEAF; PRURITUS; PSORIASIS; PURPURA; REVIEW; STRUCTURE ANALYSIS; TERATOGENICITY; ULCERATIVE COLITIS; VOMITING; WATERY DIARRHEA; WOUND;

ALOE; ANIMALS; HUMANS; PLANT EXTRACTS;

ALOE; ALOE VERA;

EID: 33646806070     PISSN: 10590501     EISSN: 15324095     Source Type: Journal    
DOI: 10.1080/10590500600614303     Document Type: Review

References (257)

1. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. Journal of the American Medical Association 1998;280:1569-1575.
2. Tindle HA, Davis RB, Phillips RS, Eisenberg DM. Trends in use of complementary and alternative medicine by US adults: 1997-2002. Altern Ther Health Med 2005;11:42-49.
3. Kaye AD, Clarke RC, Sabar R, Vig S, Dhawan KP, Hofbauer R, Kaye AM. Herbal medicines: current trends in anesthesiology practice - a hospital survey. J Clin Anesth 2000;12:468-471.
4. Cohen SM, Rousseau ME, Robinson EH. Therapeutic use of selected herbs. Holistic Nursing Practice 2000;14:59-68.
5. Angell M, Kassirer JP. Alternative medicine-the risks of untested and unregulated remedies. N Engl J Med 1998;339:839-841.
6. Davis RH, Donato JJ, Hartman GM, Haas RC. Anti-inflammatory and wound healing activity of a growth substance in Aloe vera. J Am Podiatr Med Assoc 1994;84:77-81.
7. Visuthikosol V, Chowchuen B, Sukwanarat Y, Sriurairatana S, Boonpucknavig V. Effect of aloe vera gel to healing of burn wound a clinical and histologic study. J Med Assoc Thai 1995;78:403-409.
8. Klepser TB, Doucette WR, Horton MR, Buys LM, Ernst ME, Ford JK, Hoehns JD, Kautzman HA, Logemann CD, Swegle JM, Ritho M, Klepser ME. Assessment of patients' perceptions and beliefs regarding herbal therapies. Pharmacotherapy 2000;20:83-87.
9. Vogelzang JL. What you need to know about dietary supplements. Home Healthcare Nurse 2001;19:50-52.
10. Grindlay D, Reynolds T. The Aloe vera phenomenon: A review of the properties and modern uses of the leaf parenchyma gel. J Ethnopharmacol 1986;16:117-151.
11. Lee KY, Weintraub ST, Yu BP. Isolation and identification of a phenolic antioxidant from Aloe barbadensis. Free Radical Biology and Medicine 2000;28:261-265.
12. Reynolds T, Dweck AC. Aloe vera leaf gel: A review update. J Ethnopharmacol 1999;68:3-37.
13. Briggs C. Herbal medicine: aloe. Canadian Pharmaceutical Journal 1995;128:48-50.
14. Gallagher J, Gray M. Is aloe vera effective for healing chronic wounds? J Wound Ostomy Continence Nurs 2003;30:68-71.
15. Miller MB, Koltai PJ. Treatment of experimental frostbite with pentoxifylline and Aloe vera cream. Arch Otolarnyngol Head Neck Surg 1995;121:678-680.
16. Somboonwong J, Thanamittramanee S, Jariyapongskul A, Patumraj S. Therapeutic effects of Aloe vera on cutaneous microcirculation and wound healing in second degree burn model in rats. J Med Assoc Thai 2000;83:417-425.
17. Kaufman T, Kalderon N, Ullmann Y, Berger J. Aloe vera gel hindered wound healing of experimental second-degree burns: a quantitative controlled study. J Burn Care Rehabil 1988;9:156-159.
18. Fisher J, Scott C, Stevens R, Marconi B, Champion L, Freedman GM, Asrari F, Pilepich MV, Gagnon JD, Wong G. Randomized phase III study comparing best supportive care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys 2000;48:1307-1310.
19. Thomas DR, Goode PS, LaMaster K, Tennyson T. Acemannan hydrogel dressing versus saline dressing for pressure ulcers. A randomized, controlled trial. Adv Wound Care 1998;11:273-276.
20. Seyger MM, van de Kerkhof PC, van Vlijmen-Willems IM, de Bakker ES, Zwiers F, de Jong EM. The efficacy of a new topical treatment for psoriasis: Mirak. J Eur Acad Dermatol Venereol 1998;11:13-18.
21. Chithra P, Sajithlal GB, Chandrakasan G. Influence of aloe vera on the healing of dermal wounds in diabetic rats. J Ethnopharmacol 1998;59:195-201.
22. Chithra P, Sajithlal GB, Chandrakasan G. Influence of Aloe vera on the glycosaminoglycans in the matrix of healing dermal wounds in rats. J Ethnopharmacol 1998;59:179-186.
23. Davis RH, Leitner MG, Russo JM. Aloe vera. A natural approach for treating wounds, edema, and pain in diabetes. J Am Podiatr Med Assoc 1988;78:60-68.
24. Davis RH, Kabbani JM, Maro NP. Aloe vera and wound healing. J Am Podiatr Med Assoc 1987;77:165-169.
25. Muller MJ, Hollyoak MA, Moaveni Z, Brown TL, Herndon DN, Heggers JP. Retardation of wound healing by silver sulfadiazine is reversed by Aloe vera and nystatin. Burns 2003;29:834-836.
26. Roesler J, Steinmuller C, Kiderlen A, Emmendorffer A, Wagner H, Lohmann-Matthes ML. Application of purified polysaccharides from cell cultures of the plant Echinacea purpurea to mice mediates protection against systemic infections with Listeria monocytogenes and Candida albicans. Int J Immunopharmacol 1991;13:27-37.
27. Ernst E. Adverse effects of herbal drugs in dermatology. Br J Dermatol 2000;143:923-929.
28. Aloe Vera Healer Web site. www.aloeandwellness.co.uk. Vol. 2005: JoJaffa Limited, Nantwich, Cheshire, UK, 2005.
29. Miracle of Aloe Web site: http://www.miracleofaloe.com. Vol. 2005, 2003.
30. Forever Living Web site: http://www.foreverliving.com. Vol. 2005, 2005.
31. Marshall JM. Aloe vera gel: what is the evidence? Pharm J 1990;244:360-362.
32. Imanishi K, Suzuki I. Augmentation of natural cell-mediated cytotoxic reactivity of mouse lymphoid cells by aloctin A. Int J Immunopharmacol 1984;6:539-543.
33. Imanishi K, Suzuki I. Induction of nonspecific cell-mediated cytotoxic reactivity from non-immune spleen cells treated with aloctin A. Int J Immunopharmacol 1986;8:781-787.
34. Imanishi K, Tsukuda K, Suzuki I. Augmentation of lymphokine-activated killer cell activity in vitro by aloctin A. Int J Immunopharmacol 1986;8:855-858.
35. Keum YS, Park KK, Lee JM, Chun KS, Park JH, Lee SK, Kwon H, Surh YJ. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett 2000;150:41-48.
36. Kim HS, Kacew S, Lee BM. In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis Miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 1999;20:1637-1640.
37. Zhao J, Wang J, Chen Y, Agarwal R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 1999;20:1737-1745.
38. Imanishi K, Ishiguro T, Saito H, Suzuki I. Pharmacological studies on a plant lectin, Aloctin A. I. Growth inhibition of mouse methylcholanthrene- induced fibrosarcoma (Meth A) in ascites form by Aloctin A. Experientia 1981;37:1186-1187.
39. Hanley DC, Solomon WA, Saffran B, Davis RH. The evaluation of natural substances in the treatment of adjuvant arthritis. J Am Podiatry Assoc 1982;72:275-284.
40. Davis RH, Agnew PS, Shapiro E. Antiarthritic activity of anthraquinones found in aloe for podiatric medicine. J Am Podiatr Med Assoc 1986;76:61-66.
41. Spoerke DG, Ekins BR. Aloe vera - fact or quackery. Vet Hum Toxicol 1980;22:418-424.
42. Davis RH, Stewart GJ, Bregman PJ. Aloe vera and the inflamed synovial pouch model. J Am Podiatr Med Assoc 1992;82:140-148.
43. Dykman KD, Tone C, Ford C, Dykman RA. The effects of nutritional supplements on the symptoms of fibromyalgia and chronic fatigue syndrome. Integr Physiol Behav Sci 1998;33:61-71.
44. Pecere T, Gazzola MV, Mucignat C, Parolin C, Vecchia FD, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M, Palu G. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer Res 2000;60:2800-2804.
45. Ajabnoor MA. Effect of aloes on blood glucose levels in normal and alloxan diabetic mice. J Ethnopharmacol 1990;28:215-220.
46. Bunyapraphatsara N, Yongchaiyudha S, Rungpitarangsi V, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. II. Clinical trail in diabetes mellitus patients in combination with glibenclamide. Phytomedicine 1996;3:245-248.
47. Ghannam N, Kingston M, Al-Meshaal IA, Tariq M, Parman NS, Woodhouse N. The antidiabetic activity of aloes: preliminary clinical and experimental observations. Horm Res 1986;24:288-294.
48. Roman-Ramos R, Flores-Saenz JL, Partida-Hernandez G, Lara-Lemus A, Alarcon-Aguilar F. Experimental study of the hypoglycemic effect of some antidiabetic plants. Arch Invest Med (Mex) 1991;22:87-93.
49. Yongchaiyudha S, Rungpitarangsi V, Bunyapraphatsara N, Chokechaijaroenporn O. Antidiabetic activity of Aloe vera L. juice. I. Clinical trial in new cases of diabetes mellitus. Phytomedicine 1996;3:241-243.
50. Saito H, Imanishi K, Okabe S. Effects of aloe extracts, aloctin A, on gastric secretion and on experimental gastric lesions in rats. Yakugaku Zasshi 1989;109:335-339.
51. Atherton P. Aloe vera: magic or medicine? Nurs Stand 1998;12:49-54.
52. Teradaira R, Shinzato M, Beppu H, Fujita H. Antigastric ulcer effects in rats of Aloe arborescens Miller var. natalensis berger extract. Phytother Res 1993;7:S34-S36.
53. Hutter JA, Salman M, Stavinoha WB, Satsangi N, Williams RF, Streeper RT, Weintraub ST. Antiinflammatory C-glucosyl chromone from Aloe barbadensis. J Nat Prod 1996;59:541-543.
54. Davis RH, Leitner MG, Russo JM. Topical anti-inflammatory activity of Aloe vera as measured by ear swelling. J Am Podiatr Med Assoc 1987;77:610-612.
55. Hecht A. The overselling of aloe vera. FDA Consumer 1981;15:27-29.
56. Klein AD, Penneys NS. Aloe vera. J Am Acad Dermatol 1988;18:714-720.
57. Femenia A, Sanchez ES, Simal S, Rossello C. Compositional features of polysacchardies from Aloe vera (Aloe barbadensis Miller) plant tissues. Carbohydrate Polymers 1999;39:109-117.
58. Turner CE, Williamson DA, Stroud PA, Talley DJ. Evaluation and comparison of commercially available Aloe vera L. products using size exclusion chromatography with refractive index and multi-angle laser light scattering detection. Int Immunopharmacol 2004;4:1727-1737.
59. Paez A, Gebre GM, Gonzalez ME, Tschaplinski TJ. Growth, soluble carbohydrates, and aloin concentration of Aloe vera plants exposed to three irradiance levels. Environmental and Experimental Botany 2000;44:133-139.
60. Bouthet CF, Schirf VR, Winters WD. Stimulation of neuron-like cell growth by aloe substances. Phytother Res 1995;9:185-188.
61. Yagi A, Egusa T, Arase M, Tanabe M, Tsuji H. Isolation and characterization of the glycoprotein fraction with a proliferation-promoting activity on human and hamster cells in vitro from Aloe vera gel. Planta Med 1997;63:18-21.
62. Viljoen AM, van Wyk BE. The chemotaxonomic significance of the phenyl pyrone aloenin in the genus Aloe. Biochem Syst Ecol 2000;28:1009-1017.
63. Eshun K, He Q. Aloe vera: a valuable ingredient for the food, pharmaceutical and cosmetic industries - a review. Crit Rev Food Sci Nutr 2004;44:91-96.
64. Takahashi M, Konaka D, Sakamoto A, Morikawa H. Nocturnal uptake and assimilation of nitrogen dioxide by C3 and CAM plants. Z Naturforsch [C] 2005;60:279-284.
65. Ni Y, Turner D, Yates KM, Tizard I. Isolation and characterization of structural components of Aloe vera L. leaf pulp. Int Immunopharmacol 2004;4:1745-1755.
66. Saccu D, Bogoni P, Procida G. Aloe exudate: characterization by reversed phase HPLC and headspace GC-MS. J Agric Food Chem 2001;49:4526-4530.
67. Yaron A. Characterization of Aloe vera gel before and after autodegradation, and stabilization of the natural fresh gel. Phytother Res 1993;7:11-13.
68. Shelton RM. Aloe vera. Its chemical and therapeutic properties. Int J Dermatol 1991;30:679-683.
69. Wang YT, and Strong KJ. Two-year study monitoring several physical and chemical properties of field-grown Aloe barbadensis Miller leaves. Subtropical Plant Science 1995;47:34-38.
70. Genet WBM, van Schooten CAM. Water requirements of Aloe vera in a dry Carribean climate. Irrig Sci 1992;13:81-85.
71. Waller TA, Pelley RP, Strickland FM. Industrial processing and quality control of Aloe barbadensis. In: T. Reynolds, ed. Aloes: The Genus Aloes, Boca Raton, Florida: CRC Press, 2004; Vol. 38, 139-205.
72. Robson MC, Heggers JP, Hagstrom WJ. Myth, magic, witchcraft or fact? Aloe vera revsited. J Burn Care Rehabil 1982;3:157-162.
73. Danhof IE. Position statement on polysaccharides. [http://www.gothica. com], 1998.
74. Gowda DC, Neelisiddaiah B, Anjaneyalu YV. Structural studies of polysaccharides from Aloe vera. Carbohydrate Research 1979;72:201-205.
75. Chow JT-N., Williamson DA, Yates KM, Goux WJ. Chemical characterization of the immunomodulating polysaccharide of Aloe vera L. Carbohydrate Research, 2005;340:1131-1142.
76. Mandal G, Das A. Structure of the glucomannan isolated from the leaves of Aloe barbadensis Miller. Carbohydrate Research 1980;87:249-256.
77. Green P. Aloe vera extracts in equine clinical practice. Veterinary Times 1996;26:16-18.
78. Sheets MA, Unger BA, Giggleman GF, Jr., Tizard IR. Studies of the effect of acemannan on retrovirus infections: clinical stabilization of feline leukemia virus-infected cats. Mol Biother 1991;3:41-45.
79. Gorloff DR. Study of the organoleptic properties of the exuded mucilage from aloe barbadensis leaves. Erde International 1983;1:46-59.
80. Ross SA, ElSohly MA, Wilkins SP. Quantitative analysis of Aloe vera mucilaginous polysaccharide in commercial Aloe vera products. J AOAC International 1997;80:455-457.
81. Mandal G, Das A. Structure of the D-galactan isolated from Aloe barbadensis Miller. Carbohydrate Research 1980;86:247-257.
82. Wink M. Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective. Phytochemistry 2003;64:3-19.
83. Chauser-Volfson E, Gutterman Y. The barbaloin content and distribution in Aloe arborescens leaves according to leaf part, age, position and season. Isr. J. Plant Sci 1996;44:289-296.
84. Gutterman Y, Chauser-Volfson E. Peripheral defense strategy: variation of barbaloin content in the succulen leaf parts of Aloe arborescens Miller (liliacae). Bontanical Journal of the Linnean Society 2000;132:385-395.
85. Gutterman Y, Chauser-Volfson E. The distribution of the phenolic metabolites barbaloin, aloeresin and aloenin as a peripheral defense strategy in the succulent leaf parts of Aloe arborescens. Biochemical Systematics and Ecology 2000;28:825-838.
86. Reynolds T. Observations on the phytochemistry of the Aloe leaf-exudate compounds. Botanical Journal of the Linnean Society 1985;90:179-199.
87. Park MK, Park JH, Kim NY, Shin YG, Choi YS, Lee JG, Kim KH, Lee SK. Analysis of 13 phenolic compounds in Aloe species by high performance liquid chromatography. Phytochemical analysis 1998;9:186-191.
88. Smith T, Smith H. On aloin: the cathartic principles of aloes. Monthly Journal of Medical Science 1851;12:127-131.
89. Birch AJ, Donovan FW. Barbaloin. I. Some observations on its structure. Australian Journal of Chemistry 1955;8:523-528.
90. Reynolds T. The compounds in Aloe leaf exudates: a review. Botanical Journal of the Linnean society 1985;90:157-177.
91. Hay JE, Haynes LJ. The aloins. Part I. The structure of barbaloin. J Chem Soc 1956;3141-3147.
92. Joshi SP. Chemical constituents and biological activity of Aloe barbadensis-a review. Journal of Medicinal and Aromatic Plant Sciences 1998;20:768-773.
93. Vyth A, Kamp PE. Detection of anthraquinone laxatives in the urine. Pharm Weekbl 1979;114:456-459.
94. Che QM, Akao T, Hattori M, Kobashi K, Namba T. Isolation of a human intestinal bacterium capable of transforming barbaloin to aloe-emodin anthrone. Planta Med 1991;57:15-19.
95. Hattori M, Kanda T, Shu YZ, Akao T, Kobashi K, Namba T. Metabolism of barbaloin by intestinal bacteria. Chem Pharm Bull (Tokyo) 1988;36:4462-4466.
96. Mapp RK, McCarthy TJ. The assessment of purgative principles in aloes. Plant Medicine 1970;18:361-365.
97. Franz G, Grun M. Chemistry, occurence and biosynthesis of C-glycosyl compounds in plants. Planta Med 1983;47:131-140.
98. Groom QJ, Reynolds T. Barbaloin in Aloe species. Planta Med. 1986;52:345-348.
99. Viljoen AM, van Wyk B-E, Newton LE. The occurrence and taxonomic distribution of the anthrones aloin, aloinoside and microdontin in Aloe. Biochem Syst Ecol 2001;29:53-67.
100. Brusick D, Mengs U. Assessment of the genotoxic risk from laxative senna products. Environ Mol Mutagen 1997;29:1-9.
101. Saleem R, Faizi S, Deeba F, Siddiqui BS, Qazi MH. Anthrones from Aloe barbadensis. Phytochemistry 1997;45:1279-1282.
102. Mannitto P, Monti D, Speranza G. Studies on aloe. Part 6. Conformation and absolute configuration of aloins A and B and related 10-C-glucosyl-9- anthrones. Journal of the Chemical Society Perkin I 1990;5:1297-1300.
103. Haynes LJ, Holdsworth DK, and Russel R C-glycosyl compounds. Part VI. Aloesin, a C-glucosylchromone from Aloe sp. Journal of the Chemical Society (C), 1970;18:2581-2586.
104. Gramatica P, Monti D, Speranza G, Manitto P. Aloe revisited - the structure of aloresin A. Tetrahedron Letters 1982;23:2423-2424.
105. Okamura H, Hine N, Harada S, Fujioka T, Mihashi K, Nishi M, Miyahara K, Yagi A. Diastereomic C-glycosylanthrones of Aloe vera leaves. Phytochemistry 1997;45:1519-1522.
106. Okamura N, Asaia M, Hinea N, Yagi A. High-performance liquid chromatographic determination of phenolic compounds in Aloe species. J Chromatogr A 1996;746:225-231.
107. Zonta F, Bogoni P, Masotti P, Micali G. High-performance liquid chromatographic profiles of aloe constituents and determination of aloin in beverages, with reference to the EEC regulation for flavouring substances. J Chromatogr A 1995;718:99-106.
108. Yagi A, Nakamori J, Yamada T, Iwase H, Tanaka T, Kaneo Y, Qiu J, Orndorff S. In vivo metabolism of aloemannan. Planta Med 1999;65:417-420.
109. Rajasekaran S, Sivagnanam K, Ravi K, Subramanian S. Hypoglycemic effect of Aloe vera gel on streptozotocin-induced diabetes in experimental rats. J Med Food 2004;7:61-66.
110. Al-Awadi F, Fatania H, Shamte U. The effect of a plants mixture extract on liver gluconeogenesis in streptozotocin induced diabetic rats. Diabetes Res 1991;18:163-168.
111. Parihar MS, Chaudhary M, Shetty R, Hemnani T. Susceptibility of hippocampus and cerebral cortex to oxidative damage in streptozotocin treated mice: prevention by extracts of Withania somnifera and Aloe vera. J Clin Neurosci 2004;11:397-402.
112. Bolkent S, Akev N, Ozsoy N, Sengezer-Inceli M, Can A, Okyar A, Yanardag R. Effect of Aloe vera (L.) Burm. fil. leaf gel and pulp extracts on kidney in type-II diabetic rat models. Indian Journal of Experimental Biology 2004;42:48-52.
113. Can A, Akev N, Ozsoy N, Bolkent S, Arda BP, Yanardag R, Okyar A. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 2004;27:694-698.
114. Nasiff HA, Fajardo FR, Velez FMEdP. Efecto del aloe sobre la hiperlipidemia en pacientes refractarios a la dieta. Revista Cubana de Med Gen Integral 1993;9:43-51.
115. Agarwal OP. Prevention of atheromatous heart disease. Angiology 1985;36:485-492.
116. Danhof IE, McAnally BH. Stabilized aloe vera: Effect on human skin cells. Drug Cosmet Ind 1983;133:52-54, 101-102.
117. Hayes SM. Lichen planus - report of successful treatment with Aloe vera. Gen Dent 1999;47:268-272.
118. Winters WD, Benavides R, Clouse WJ. Effects of Aloe extracts on human normal and tumor cells in vitro. Economic Botany 1981;35:89-95.
119. Bowles WB. Aloe vera gel and its effect on cell growth. Parfumerie und Kosmetik 1994;75:660-661.
120. Akev N, Can A. Separation and some properties of Aloe vera L. leaf pulp lectins. Phytother Res 1999;13:489-493.
121. Choi SW, Son BW, Son YS, Park YI, Lee SK, Chung MH. The wound-healing effect of a glycoprotein fraction isolated from Aloe vera. Br J Dermatol 2001;145:535-545.
122. Mantle D, Gok MA, Lennard TW. Adverse and beneficial effects of plant extracts on skin and skin disorders. Adverse Drug React Toxicol Rev 2001;20:89-103.
123. Rodriguez-Bigas M, Cruz NI, Suarez A. Comparative evaluation of aloe vera in the management of burn wounds in guinea pigs. Plast Reconstr Surg 1988;81:386-389.
124. Watcher MA, Wheeland RG. The role of topical agents in the healing of full-thickness wounds. J Dermatol Surg Oncol 1989;15:1188-1195.
125. Heggers JP, Kucukcelebi A, Stabenau CJ, Ko F, Broemeling LD, Robson MC. Wound healing effects of Aloe gel and other topical antibacterial agents on rat skin. Phytother Res 1995;9:455-457.
126. Heggers JP, Kucukcelebi A, Listengarten D, Stabenau J, Ko F, Broemeling LD, Robson MC, Winters WD. Beneficial effect of Aloe on wound healing in an excisional wound model. The Journal of Alternative and Complementary Medicine 1996;2:217-277.
127. Fulton JE, Jr. The stimulation of postdermabrasion wound healing with stabilized aloe vera gel-polyethylene oxide dressing. J Dermatol Surg Oncol 1990;16:460-467.
128. Schmidt JM, Greenspoon JS. Aloe vera dermal wound gel is associated with a delay in wound healing. Obstet Gynecol 1991;78:115-117.
129. Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL, Urias RE, Kuske RR, Engel RE, Eggleston WD. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys 1996;36:345-349.
130. Heggie S, Bryant GP, Tripcony L, Keller J, Rose P, Glendenning M, Heath J. A Phase III study on the efficacy of topical Aloe vera gel on irradiated breast tissue. Cancer Nurs 2002;25:442-451.
131. Olsen DL, Raub W, Jr, Bradley C, Johnson M, Macias JL, Love V, Markoe A. The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol Nurs Forum 2001;28:543-547.
132. Paulsen E, Korsholm L, Brandrup F. A double-blind, placebo-controlled study of a commercial Aloe vera gel in the treatment of slight to moderate psoriasis vulgaris. J Eur Acad Dermatol Venereol 2005;19:326-331.
133. Syed TA, Ahmad SA, Holt AH, Ahmad SA, Ahmad SH, Afzal M. Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health 1996;1:505-509.
134. Davis RH, Leitner MG, Russo JM, Byrne ME. Wound healing. Oral and topical activity of Aloe vera. J Am Podiatr Med Assoc 1989;79:559-562.
135. Breier G, Risau W. The role of vascular endothelial growth factor in blood vessel formation. Trends Cell Biol 1996;6:454-456.
136. Bischoff J. Approaches to studying cell adhesion molecules in angiogenesis. Trends Cell Biol 1995;5:69-74.
137. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987;235:442-447.
138. Moon EJ, Lee YM, Lee OH, Lee MJ, Lee SK, Chung MH, Park YI, Sung CK, Choi JS, Kim KW. A novel angiogenic factor derived from Aloe vera gel: beta-sitosterol, a plant sterol. Angiogenesis 1999;3:117-123.
139. Lee MJ, Lee OH, Yoon SH, Lee SK, Chung MH, Park YI, Sung CK, Choi JS, Kim KW. In vitro angiogenic activity of Aloe vera gel on calf pulmonary artery endothelial (CPAE) cells. Arch Pharm Res 1998;21:260-265.
140. Choi S, Kim K-W, Choi J-S, Han S-T, Park Y-I, Lee S-K, Kim J-S, Chung M-C. Angiogenic activity of beta-sitosterol in the ischaemia/reperfusion-damaged brain of Mongolian gerbil. Planta Med 2002;68:330-335.
141. Pugh N, Ross SA, ElSohly MA, Pasco DS. Characterization of Aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity. J Agric Food Chem 2001;49:1030-1034.
142. Qiu Z, Jones K, Wylie M, Jia Q, Orndorff S. Modified Aloe barbadensis polysaccharide with immunoregulatory activity. Planta Med 2000;66:152-156.
143. Im S-A, Oh S-T, Song S, Kim M-R, Kim D-S, Woo S-S, Jo TH, Park YI, Lee C-K. Identification of optimal molecular size of modified Aloe polysaccharides with maximum immunomodulatory activity. International Immunopharmacology 2005;5:271-279.
144. Talmadge J, Chavez J, Jacobs L, Munger C, Chinnah T, Chow JT, Williamson D, Yates K. Fractionation of Aloe vera L. inner gel, purification and molecular profiling of activity. Int Immunopharmacol 2004;4:1757-1773.
145. Zhang L, Tizard IR. Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel. Immunopharmacology 1996;35:119-128.
146. Ramamoorthy L, Kemp MC, Tizard IR. Acemannan, a beta-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line RAW 264.7. Mol Pharmacol 1996;50:878-884.
147. Ramamoorthy L, Tizard IR. Induction of apoptosis in a macrophage cell line RAW 264.7 by acemannan, a beta-(1,4)-acetylated mannan. Mol Pharmacol 1998;53:415-421.
148. Karaca K, Sharma JM, Nordgren R. Nitric oxide production by chicken macrophages activated by Acemannan, a complex carbohydrate extracted from Aloe vera. Int J Immunopharmacol 1995;17:183-188.
149. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
150. Lee JK, Lee MK, Yun YP, Kim Y, Kim JS, Kim YS, Kim K, Han SS, Lee CK. Acemannan purified from A loe vera induces phenotypic and functional maturation of immature dendritic cells. Int Immunopharmacol 2001;1:1275-1284.
151. Hu Y, Xu J, Hu Q. Evaluation of antioxidant potential of Aloe vera (Aloe barbadensis Miller) extracts. Journal of Agric. Food Chemistry 2003;51:7788-7791.
152. t'Hart LA, van Enckevort PH, van Dijk H, Zaat R, de Silva KTD, Labadie RP. Two functionally and chemically distinct immunomodulatory compounds in the gel of Aloe vera. Journal of Ethnopharmacology 1988;23:61-71.
153. Rajasekaran S, Sivagnanam K, Subramanian S. Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 2005;57:90-96.
154. Saada HN, Ussama ZS, Mahdy AM. Effectiveness of Aloe vera on the antioxidant status of different tissues in irradiated rats. Pharmazie 2003;58:929-931.
155. Vázquez B, Avila G, Segura D, Escalante B. Antiinflammatory activity of extracts from Aloe vera gel. J Ethnopharmacol 1996;55:69-75.
156. Langmead L, Makins RJ, Rampton DS. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther 2004;19:521-527.
157. Duansak D, Somboonwong J, Patumraj S. Effects of Aloe vera on leukocyte adhesion and TNF-alpha and IL-6 levels in burn wounded rats. Clin Hemorheol Microcirc 2003;29:239-246.
158. Peng SY, Norman J, Curtin G, Corrier D, McDaniel HR, Busbee D. Decreased mortality of Norman murine sarcoma in mice treated with the immunomodulator, Acemannan. Mol Biother 1991;3:79-87.
159. Strickland FM, Pelley RP, Kripke ML. Prevention of ultraviolet radiation-induced suppression of contact and delayed hypersensitivity by Aloe barbadensis gel extract. J Invest Dermatol 1994;102:197-204.
160. Lee CK, Han SS, Shin YK, Chung MH, Park YI, Lee SK, Kim YS. Prevention of ultraviolet radiation-induced suppression of contact hypersensitivity by Aloe vera gel components. Int J Immunopharmacol 1999;21:303-310.
161. Byeon SW, Pelley RP, Ullrich SE, Waller TA, Bucana CD, Strickland FM. Aloe barbadensis extracts reduce the production of interleukin-10 after exposure to ultraviolet radiation. J Invest Dermatol 1998;110:811-817.
162. Penneys NS. Inhibition of arachidonic acid oxidation in vitro by vehicle components. Acta Derm Venereol 1982;62:59-61.
163. Crowell J, Hilsenbeck S, Penneys N. Aloe vera does not affect cutaneous erythema and blood flow following ultraviolet B exposure. Photodermatol 1989;6:237-239.
164. Langmead L, Feakins RM, Goldthorpe S, Holt H, Tsironi E, De Silva A, Jewell DP, Rampton DS. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther 2004;19:739-747.
165. Womble D, Helderman JH. Enhancement of allo-responsiveness of human lymphocytes by acemannan (Carrisyn). Int J Immunopharmacol 1988;10:967-974.
166. Gelderman MP, Lefkowitz DL, Lefkowitz SS, Bollen A, Moguilevsky N. Exposure of macrophages to an enzymatically inactive macrophage mannose receptor ligand augments killing of Candida albicans. Proc Soc Exp Biol Med 1998;217:81-88.
167. Stuart RW, Lefkowitz DL, Lincoln JA, Howard K, Gelderman MP, Lefkowitz SS. Upregulation of phagocytosis and candidicidal activity of macrophages exposed to the immunostimulant acemannan. Int J Immunopharmacol 1997;19:75-82.
168. Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration. Virology 2003;308:1-12.
169. Yates KM, Rosenberg LJ, Harris CK, Bronstad DC, King GK, Biehle GA, Walker B, Ford CR, Hall JE, Tizard IR. Pilot study of the effect of acemannan in cats infected with feline immunodeficiency virus. Vet Immunol Immunopathol 1992;35:177-189.
170. Kahlon JB, Kemp MC, Yawei N, Carpenter RH, Shannon WM, McAnalley BH. In vitro evaluation of the synergistic antiviral effects of acemannan in combination with azidothymidine and acyclovir. Mol Biother, 1991;3:214-223.
171. Ferro VA, Bradbury F, Cameron P, Shakir E, Rahman SR, Stimson WH. In vitro susceptibilities of Shigella flexneri and Streptococcus pyogenes to inner gel of Aloe barbadensis Miller. Antimicrob Agents Chemother 2003;47:1137-1139.
172. Moody JO, Adebiyi OA, Adeniyi BA. Do Aloe vera and Ageratum conyzoides enhance the anti-microbial activity of traditional medicinal soft soaps (Osedudu)? J Ethnopharmacol 2004;92:57-60.
173. Harris C, Pierce K, King G, Yates KM, Hall J, Tizard I. Efficacy of acemannan in treatment of canine and feline spontaneous neoplasms. Mol Biother 1991;3:207-213.
174. King GK, Yates KM, Greenlee PG, Pierce KR, Ford CR, McAnalley BH, Tizard IR. The effect of Acemannan Immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas. J Am Anim Hosp Assoc 1995;31:439-447.
175. Kim HS, Lee BM. Inhibition of benzo[a]pyrene-DNA adduct formation by Aloe barbadensis Miller. Carcinogenesis 1997;18:771-776.
176. Shamaan NA, Kadir KA, Rahmat A, Ngah WZ. Vitamin C and aloe vera supplementation protects from chemical hepatocarcinogenesis in the rat. Nutrition, 1998;14:846-852.
177. Lissoni P, Giani L, Zerbini S, Trabattoni P, Rovelli F. Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus Aloe vera in untreatable advanced solid neoplasms. Nat Immun 1998;16:27-33.
178. Fogleman RW, Chapdelaine JM, Carpenter RH, McAnalley BH. Toxicologic evaluation of injectable acemannan in the mouse, rat and dog. Vet Hum Toxicol 1992;34:201-205.
179. Fogleman RW, Shellenberger TE, Balmer MF, Carpenter RH, McAnalley BH. Subchronic oral administration of acemannan in the rat and dog. Vet Hum Toxicol 1992;34:144-147.
180. Shah AH, Quereshi S, Tariq M, Ageel AM. Toxicity studies on six plants used in the traditional arab system of medicine. Phytother Res 1989;3:25-28.
181. Herlihy JT, Bertrand HA, Kim JD, Ikeno Y, Yu BP. Effects of aloe vera ingestion in the rat I. Growth, food and fluid intake and serum chemistry. Phytother Res 1998;12:183-188.
182. Herlihy JT, Kim JD, Katu DN, Nelson JF, Ward WF, Ikeno Y, Yu BP. Effects of aloe vera ingestion in the rat. II. Hormonal and metabolic characteristics. Phytother Res 1998;12:355-360.
183. Ikeno Y, Hubbard GB, Lee S, Yu BP, Herlihy JT. The influence of long-term Aloe vera ingestion on age-related disease in male Fischer 344 rats. Phytother Res 2002;16:712-718.
184. Lim BO, Seong NS, Choue RW, Kim JD, Lee HY, Kim SY, Yu BP, Jeon TI, Park DK. Efficacy of dietary aloe vera supplementation on hepatic cholesterol and oxidative status in aged rats. J Nutr Sci Vitaminol (Tokyo) 2003;49:292-296.
185. Rabe C, Musch A, Schirmacher P, Kruis W, Hoffmann R. Acute hepatitis induced by an Aloe vera preparation: a case report. World J Gastroenterol 2005;11:303-304.
186. Mascolo N, Izzo AA, Borelli F, Capasso R, DiCarlo G, Sautebin L, Capasso F. Healing powers of aloes. In: T. Reynolds ed. Aloes: The Genus Aloe, 2003 edition, Boca Raton, FL: CRC Press, 2004; Vol. 38, 209-238.
187. Dominguez-Soto L. Photodermatitis to aloe vera. Int J Dermatol 1992;31:372.
188. Hunter D, Frumkin A. Adverse reactions to vitamin E and aloe vera preparations after dermabrasion and chemical peel. Cutis 1991;47:193-196.
189. Morrow DM, Rapaport MJ, Strick RA. Hypersensitivity to aloe. Arch Dermatol 1980;116:1064-1065.
190. Hattori M, Akao T, Kobashi K, Namba T. Cleavages of the O- and C-glucosyl bonds of anthrone and 10,10′-bianthrone derivatives by human intestinal bacteria. Pharmacology 1993;47 (Suppl 1):125-133.
191. van Gorkom BA, de Vries EG, Karrenbeld A, Kleibeuker JH. Review article: anthranoid laxatives and their potential carcinogenic effects. Aliment Pharmacol Ther 1999;13:443-452.
192. Akao T, Che QM, Kobashi K, Hattori M, Namba T. A purgative action of barbaloin is induced by Eubacterium sp. strain BAR, a human intestinal anaerobe,
193. deWitte P. Metabolism and pharmacokinetics of anthranoids. Pharmacology 1993;47:86-97.
194. Sendelbach LE. A review of the toxicity and carcinogenicity of anthraquinone derivatives. Toxicology 1989;57:227-240.
195. Stolk LM, Hoogtanders K. Detection of laxative abuse by urine analysis with HPLC and diode array detection. Pharm World Sci 1999;21:40-43.
196. de Witte P, Lemli L. The metabolism of anthranoid laxatives. Hepatogastroenterol 1990;37:601-605.
197. Lang W. Pharmacokinetic-metabolic studies with 14C-aloe emodin after oral administration to male and female rats. Pharmacology 1993;47 (Suppl 1):110-119.
198. Krumbiegel G, Schulz HU. Rhein and aloe-emodin kinetics from senna laxatives in man. Pharmacology 1993;47 (Suppl 1):120-124.
199. Fantus B. Aloes as a medicine. Journal of the American Pharmaceutical Association 1922;11:616-621.
200. Ishii Y, Tanizawa H, Takino Y. Rat selection test with respect to laxative activity induced by barbaloin. Biol Pharm Bull 1993;16:1040.
201. Ishii Y, Takino Y, Toyo'oka T, Tanizawa H. Studies of aloe. VI. Cathartic effect of isobarbaloin. Biol Pharm Bull 1998;21:1226-1227.
202. Ishii Y, Tanizawa H, Takino Y. Studies of aloe. III. Mechanism of cathartic effect. (2). Chem Pharm Bull (Tokyo) 1990;38:197-200.
203. Koch A. Metabolism of aloin-the influence of nutrition. J Pharm Biomed Anal 1996;14:1335-1338.
204. Yagi T, Yamauchi K. Synergistic effects of anthraquinones on the purgative activity of rhein anthrone in mice. J Pharm Pharmacol 1999;51:93-95.
205. Ishii Y, Tanizawa H, Takino Y. Studies of aloe. V. Mechanism of cathartic effect. (4). Biol Pharm Bull 1994;17:651-653.
206. Capasso F, Mascolo N, Autore G, Duraccio MR. Effect of indomethacin on aloin and 1,8 dioxianthraquinone-induced production of prostaglandins in rat isolated colon. Prostaglandins 1983;26:557-562.
207. Kai M, Hayashi K, Kaida I, Aki H, Yamamoto M. Permeation-enhancing effect of aloe-emodin anthrone on water-soluble and poorly permeable compounds in rat colonic mucosa. Biol Pharm Bull 2002;25:1608-1613.
208. Izzo AA, Mascolo N, Capasso F. Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci 1998;43:1605-1620.
209. Izzo AA, Sautebin L, Borrelli F, Longo R, Capasso F. The role of nitric oxide in aloe-induced diarrhoea in the rat. Eur J Pharmacol 1999;368:43-48.
210. Mijatovic S, Maksimovic-Ivanic D, Radovic J, Popadic D, Momcilovic M, Harhaji L, Miljkovic D, Trajkovic V. Aloe-emodin prevents cytokine-induced tumor cell death: the inhibition of auto-toxic nitric oxide release as a potential mechanism. Cell Mol Life Sci 2004;61:1805-1815.
211. Barrantes E, Guinea M. Inhibition of collagenase and metalloproteinases by aloins and aloe gel. Life Sci 2003;72:843-850.
212. 'tHart LA, Nibbering PH, Barselaar MTVD, Dijk HV, Berg AJVD, P.Labadie R. Effects of low molecular constituents from Aloe vera gel on oxidative metabolism and cytotoxic and bactericidal activities of human neutrophils. Int J Immunopharmacol 1990;12:427-434.
213. Alves DS, Perez-Fons L, Estepa A, Micol V. Membrane-related effects underlying the biological activity of the anthraquinones emodin and barbaloin. Biochem Pharmacol 2004;68:549-561.
214. Sydiskis RJ, Owen DG, Lohr JL, Rosler KH, Blomster RN. Inactivation of enveloped viruses by anthraquinones extracted from plants. Antimicrob Agents Chemother 1991;35:2463-2466.
215. Andersen DO, Weber ND, Wood SG, Hughes BG, Murray BK, North JA. In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antiviral Res 1991;16:185-196.
216. Levin H, Hazenfratz R, Friedman J, Pelevitch D, Perl M. Partial purification and some properties of an antibacterial compound from Aloe vera. Phytother Res 1988;2:67-69.
217. Friedmann CA. Structure-activity relationships of anthraquinones in some pathological conditions. Pharmacology 1980;20:113-122.
218. Yen G-C, Duh P-D, Chuang D-Y. Antioxidant activity of anthraquinones and anthrone. Food Chemistry 2000;70:437-441.
219. Arosio B, Gagliano N, Fusaro LM, Parmeggiani L, Tagliabue J, Galetti P, De Castri D, Moscheni C, Annoni G. Aloe-emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride. Pharmacol Toxicol 2000;87:229-233.
220. Wamer WG, Vath P, Falvey DE. In vitro studies on the photobiological properties of aloe emodin and aloin A. Free Radical Biology and Medicine 2003;34:233-242.
221. Vargas F, Fraile G, Velasquez M, Correia H, Fonseca G, Marin M, Marcano E, Sanchez Y. Studies on the photostability and phototoxicity of aloe-emodin, emodin and rhein. Pharmazie 2002;57:399-404.
222. Vath P, Wamer WG, Falvey DE. Photochemistry and phototoxicity of aloe emodin. Photochem Photobiol 2002;75:346-352.
223. Grimaudo S, Tolomeo M, Gancitano RA, D'Alessandro N, Aiello E. Effects of highly purified anthraquinoid compounds from Aloe vera on sensitive and multidrug resistant leukemia cells. Oncology Reports 1997;4:341-343.
224. Chen HC, Hsieh WT, Chang WC, Chung JG. Aloe-emodin induced in vitro G2/M arrest of cell cycle in human promyelocytic leukemia HL-60 cells. Food Chem Toxicol 2004;42:1251-1257.
225. Lee HZ. Protein kinase C involvement in aloe-emodin- and emodin-induced apoptosis in lung carcinoma cell. Br J Pharmacol 2001;134:1093-1103.
226. Lee HZ, Hsu SL, Liu MC, Wu CH. Effects and mechanisms of aloe-emodin on cell death in human lung squamous cell carcinoma. Eur J Pharmacol 2001;431:287-295.
227. Yeh FT, Wu CH, Lee HZ. Signaling pathway for aloe-emodin-induced apoptosis in human H460 lung nonsmall carcinoma cell. Int J Cancer 2003;106:26-33.
228. Kuo PL, Lin TC, Lin CC. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines. Life Sci 2002;71:1879-1892.
229. Mijatovic S, Maksimovic-Ivanic D, Radovic J, Miljkovic D, Kaludjerovic GN, Sabo TJ, Trajkovic V. Aloe emodin decreases the ERK-dependent anticancer activity of cisplatin. Cell Mol Life Sci 2005;18:5041-5043.
230. Westendorf J, Marquardt H, Poginsky B, Dominiak M, Schmidt J, Marquardt H. Genotoxicity of naturally occurring hydroxyanthraquinones. Mutat Res 1990;240:1-12.
231. Mueller SO, Eckert I, Lutz WK, Stopper H. Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: topoisomerase II mediated? Mutat Res 1996;371:165-173.
232. Kodama M, Kamioka Y, Nakayama T, Nagata C, Morooka N, Ueno Y. Generation of free radical and hydrogen peroxide from 2-hydroxyemodin, a direct-acting mutagen, and DNA strand breaks by active oxygen. Toxicol Lett 1987;37:149-156.
233. Mueller SO, Lutz WK, Stopper H. Factors affecting the genotoxic potency ranking of natural anthraquinones in mammalian cell culture systems. Mutat Res 1998;414:125-129.
234. Mueller SO, Stopper H, Dekant W. Biotransformation of the anthraquinones emodin and chrysophanol by cytochrome P450 enzymes. Bioactivation to genotoxic metabolites. Drug Metab Dispos 1998;26:540-546.
235. Mueller SO, Stopper H. Characterization of the genotoxicity of anthraquinones in mammalian cells. Biochim Biophys Acta 1999;1428:406-414.
236. Wolfe D, Schmutte C, Westendorf J, Marquardt H. Hydroxyanthraquinones as tumor promoters: enhancement of malignant transformation of C3H mouse fibroblasts and growth stimulation of primary rat hepatocytes. Cancer Res 1990;50:6540-6544.
237. Schorkhuber M, Richter M, Dutter A, Sontag G, Marian B. Effect of anthraquinone-laxatives on the proliferation and urokinase secretion of normal, premalignant and malignant colonic epithelial cells. Eur J Cancer 1998;34:1091-1098.
238. Cooke WT. Laxative abuse. Acta Gastro-Enterol Belg 1981;44:448-458.
239. Heizer WD, Warshaw AL, Waldmann TA, Laster L. Protein-losing gastroenteropathy and malabsorption associated with factitious diarrhea. Ann Intern Med 1968;68:839-852.
240. Perkins JG, Petersen AB, Riley JA. Renal and cardiac lesions in potassium deficiency due to chronic diarrhea. Am J Med 1950;8:115-123, illust.
241. Evangelos C, Spyros K, Spyros D. Henoch-Schonlein purpura associated with Aloe vera administration. Eur J Intern Med 2005;16:59-60.
242. Luyckx VA, Ballantine R, Claeys M, Cuyckens F, Van den Heuvel H, Cimanga RK, Vlietinck AJ, Broe ME, Katz IJ. Herbal remedy-associated acute renal failure secondary to Cape aloes. American Journal of Kidney Diseases 2002;39:1-5.
243. Abebe W. An overview of herbal supplement utilization with particular emphasis on possible interactions with dental drugs and oral manifestations. J Dent Hyg 2003;77:37-46.
244. Siegers CP. von Hertzberg-Lottin E, Otte M, and Schneider B. Anthranoid laxative abuse - a risk for colorectal cancer? Gut 1993;34:1099-1101.
245. Willems M, van Buuren HR, de Krijger R. Anthranoid self-medication causing rapid development of melanosis coli. Neth J Med 2003;61:22-24.
246. Strickland FM, Muller HK, Stephens LC, Bucana CD, Donawho CK, Sun Y, Pelley RP. Induction of primary cutaneous melanomas in C3H mice by combined treatment with ultraviolet radiation, ethanol and aloe emodin. Photochem Photobiol 2000;72:407-414.
247. Badgwell DB, Walker CM, Baker WT, Strickl FM. Ethanol and aloe emodin alter the p53 mutational spectrum in ultraviolet radiation-induced murine skin tumors. Mol Carcinog 2004;39:127-138.
248. Alles MS, Hartemink R, Meyboom S, Harryvan JL, Van Laere KM, Nagengast FM, Hautvast JG. Effect of transgalactooligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer. Am J Clin Nutr 1999;69:980-991.
249. Cummings JH, Bingham SA. Diet and the prevention of cancer. British Medical Journal 1998;317:1636-1640.
250. Cummings JH. Dietary carbohydrates and the colonic microflora. Curr Opin Clin Nutr Metab Care 1998;1:409-414.
251. Yuan H, Liddle FJ, Mahajan S, Frank DA. IL-6-induced survival of colorectal carcinoma cells is inhibited by butyrate through down-regulation of the IL-6 receptor. Carcinogenesis 2004;25:2247-2255.
252. Cummings JH, Macfarlane GT. Role of intestinal bacteria in nutrient metabolism. JPEN J Parenter Enteral Nutr 1997;21:357-365.
253. Chapman M. Re: Excessively high cell proliferation in sigmoid colon after an oral purge with anthraquinone glycosides [letter; comment]. J Natl Cancer Inst 1995;87:1086-1087.
254. Borins M. The danger of using herbs: what your patients need to know. Postgraduate Medicine 1998;104:91-100.
255. Schenkel B, Vorherr H. Non-prescription drugs during pregnancy: potential teratogenic and toxic effects upon embryo and fetus. J Reprod Med 1974;12:27-45.
256. Mori H, Sugie S, Niwa K, Takahashi M, Kawai K. Induction of intestinal tumours in rats by chrysazin. Br J Cancer 1985;52:781-783.
257. Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999;49:823-828.